Belize vs Papua New Guinea: Previously treated cases tested for RR-/MDR-TB
Belize
100.0%
in 2024
Papua New Guinea
100.0%
in 2024
Belize rank
1st
Papua New Guinea rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Belize
- Papua New Guinea
How they compare
Belize currently reports 100.0% against 100.0% in Papua New Guinea, a difference of 0.0%.
Across all 5 years both countries report, Papua New Guinea has been ahead every year.
Belize ranks 1st and Papua New Guinea ranks 1st of 180 countries.
Papua New Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belize | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 19.2% | 43.3% | 24.1% | Papua New Guinea |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Belize or Papua New Guinea?
- Belize, at 100.0% against 100.0% in Papua New Guinea as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Belize and Papua New Guinea?
- 0.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Papua New Guinea?
- 5 years are reported by both, from 2015 to 2024.
- How do Belize and Papua New Guinea rank globally for previously treated cases tested for rr-/mdr-tb?
- Belize ranks 1st and Papua New Guinea ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.